Skip to main content

Timing of Palliative Care Consultations – Is Earlier Better?



Growth in inpatient palliative care over the last decade has been remarkable. A study published this month showed that in 1998 only 15% of hospitals with more than 50 beds had an inpatient palliative care program. That numbers is now 67% nationally. While this is great news, one can't help to think that the majority of patients facing a serious illness, such as advanced cancer, are not in the hospital. A study published this week in  JPM by Colin Scibetta Colin, Kathleen Kerr, Joseph Mcguire, and Mike Rabow gives us more weight when advocating for improved early access to palliative care through the delivery of outpatient consultations.

What they did

The authors included patients with solid tumors who died between January 2010 and May 2012 and who received care in the final 6 months of life at the UCSF Helen Diller Family Comprehensive Cancer Center. They used claims data to identify patients who had involvement by either the outpatient or inpatient palliative care service. The categorized these indivudals as either having:
  1. early palliative care: the initial palliative care contact occurred more than 90 days before death
  2. late palliative care: the initial contact was within the last 90 days of life.
The outcomes of interest included NQF EOL quality metrics to assess differences in utilization (ICU days in final month of life and multiple emergency department visits in the final month of life) as well as death in the acute care setting, 30-day mortality, death within 3 days of hospital discharge, and inpatient admissions in the last month of life. They also looked at direct cost of care to the health system for care delivered in the inpatient and outpatient settings in the 6 months preceding death.

What they found

Among the 297 decidents included in this study, 93 (31.5%) had early palliative care, while 204 (22.1%) had late-palliative care. Both the early and late group looked the same, except that patients with urologic or gynecologic cancers were more likely to have early palliative care than those with other cancers. Most of the early palliative care was attributed to being seen as an outpatient, while late palliative care was mostly delivered in the hospital, despite being seen in an outpatient oncology clinic during the 91–180 days prior to death.

Utilization – earlier is better

Compared to the later palliative care group, those who got early palliative care had:

  • lower rates of inpatient admissions in the last 30 days of life (33% versus 66%)
  • lower rates of ICU use in last month of life (5% versus 20%) 
  • fewer emergency department visits in the last month of life (34% versus 54%) 
  • a lower rate of inpatient death (15% versus 34%) 
  • fewer deaths within three days of hospital discharge (16% versus 39%)
  • lower 30-day mortality rates post hospital admission (33% versus 66%)

Cost of care – earlier is better

Compared to patients who had late palliative care, the early palliative care group had significantly less direct costs ($32,095/patient versus $37,293/patient). This was largely due to a significant decrease in inpatient direct costs (average of $19,067/patient versus $25,754/patient, p = 0.006), as the direct costs for outpatient care in the final 6 months of life were not statistically significantly different (average of $13,040/patient versus $11,549/patient), p = 0.85).

Take Home Points

I think there are three main take home points from this study:

1) If you want to significantly improve early access to palliative care, you must deliver this care outside of the hospital setting. We’ve seen this with our own data at our medical center. The second we opened up a palliative care clinic nearly a decade ago, our time from consult to death increased from a little less to a month to now over half a year.

2) If you improve early access to palliative care by developing an outpatient clinic, you will see a drop in inpatient deaths. Again, we’ve seen this in our own medical center.   The drop in inpatient deaths though creates problems if quality metrics are only measuring what happens to inpatient deaths (the easiest deaths to capture).  For high quality metrics, all deaths need to be captured, something that is difficult in a fragmented health care system.

3) The delivery of high quality of care can also be cost-effective care. This study further adds to the growing list of studies that palliative care can not only can improve the quality of care for patients with serious illness, but can do it in a way that also reduces total health care costs.

by: Eric Widera (@ewidera)

Comments

Jim Richardson said…
This comment has been removed by the author.
Jim Richardson said…
Could you please elaborate on your experience with patients with non-oncologic diagnoses? Have you published your data? Thank you.
Anonymous said…
Please remember that while 67% of hospitals state they have a palliative care program, at my institution, I was the program, the only person, and eventually burnt out.

Paul
Joanne Lynn said…
This is a very helpful study. It is, of course, subject to bias as an observational study, but the experience of many people bear it out. I'd love to be able to see the effect of palliative/geriatric approaches in the more common frailty syndromes with long, drawn-out, less predictable courses. I think that the effect would be at least as much, but the marker (palliative specialist consultation) would be almost irrelevant, since most of the care planning and supportive services needed in this trajectory are not dependent upon or provided by palliative care specialists.
From another perspective, the call to find a way to report on all deaths, and not just hospital deaths, is leading me to work on a death certificate follow-back method, with which we could tally progress (or lack thereof) in a community. If anyone is working with the same idea, or would like to, be in touch.

Popular posts from this blog

Geroscience and it's Impact on the Human Healthspan: A podcast with John Newman

Ok, I'll admit it. When I hear the phrase "the biology of aging" I'm mentally preparing myself to only understand about 5% of what the presenter is going to talk about (that's on a good day).  While I have words like telomeres, sirtuins, or senolytics memorized for the boards, I've never been able to see how this applies to my clinical practice as it always feels so theoretical.  Well, today that changed for me thanks to our podcast interview with John Newman, a "geroscientist" and geriatrician here at UCSF and at the Buck Institute for Research on Aging.

In this podcast, John breaks down what geroscience is and how it impacts how we think about many age-related conditions and diseases. For example, rather than thinking about multimorbidity as the random collection of multiple different clinical problems, we can see it as an expression of the fundamental mechanisms of aging. This means, that rather than treating individuals diseases, targeting …

The Dangers of Fleet Enemas

The dangers of oral sodium phosphate preparations are fairly well known in the medical community. In 2006 the FDA issued it’s first warning that patients taking oral sodium phosphate preparations are at risk for potential for acute kidney injury. Two years later, over-the-counter preparations of these drugs were voluntarily withdrawn by the manufacturers.  Those agents still available by prescription were given black box warnings mainly due to acute phosphate nephropathy that can result in renal failure, especially in older adults. Despite all this talk of oral preparations, little was mentioned about a sodium phosphate preparation that is still available over-the-counter – the Fleet enema.

Why Oral Sodium Phosphate Preparations Are Dangerous 

Before we go into the risks of Fleet enemas, lets spend just a couple sentences on why oral sodium phosphate preparations carry significant risks. First, oral sodium phosphate preparations can cause significant fluid shifts within the colon …

Length of Stay in Nursing Homes at the End of Life

One out of every four of us will die while residing in a nursing home. For most of us, that stay in a nursing home will be brief, although this may depend upon social and demographic variables like our gender, net worth, and marital status. These are the conclusions of an important new study published in JAGS by Kelly and colleagues (many of whom are geripal contributors, including Alex Smith and Ken Covinsky).

The study authors used data from the Health and Retirement Study (HRS) to describe the lengths of stay of older adults who resided in nursing homes at the end of life. What they found was that out of the 8,433 study participants who died between 1992 and 2006, 27.3% of resided in a nursing home prior to their death. Most of these patients (70%) actually died in the nursing home without being transferred to another setting like a hospital.

 The length of stay data were striking:

the median length of stay in a nursing home before death was 5 months the average length of stay was l…